Skip to main content
Clinical Trials/CTRI/2020/08/027195
CTRI/2020/08/027195Not yet recruitingNot Applicable

Lactate Clearance And Modified Sepsis Neonatal Score As Markers Of Adverse Outcomes In Neonates With Sepsis

SHUBHIKA GARG1 site in 1 country68 target enrollmentStarted: August 25, 2020Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
68
Locations
1
Primary Endpoint
Mortality

Study Overview

Brief Summary

Neonatal sepsis is one of the major health problems in neonatal care. It has a high mortality rate of 18 per 1000 live births. To call a neonate in sepsis, a positive blood culture constitutes the gold standard. It is divided into 2 groups- Early onset sepsis(≤72hrs of life) and Late onset sepsis(>72hrs of life)

Blood lactate concentration is a marker of onset of tissue hypoxia, which is the risk factor for death in neonatal sepsis.

In practice there are various clinical scoring system for neonatal sepsis like CRIB(clinical risk index for baby score) II, SNAP(score for neonatal acute physiology)-II, SNAPPE(score for neonatal acute physiology-perinatal extension)-II, MSNS(modified sepsis neonatal score) for prediction of prognosis. In this study we are using MSNS score.

So we will take both these parameters to assess To study number of newborn deaths occurring in infants with lactate clearance <10% and Modified Sepsis Neonatal Score≤10 till 28days or earlier.

Neonates upto 7days will be taken in for study who fulfill the inclusion criteria and outcome evaluation is done at recruitment and 6hours later of first starting the treatment

Study Design

Study Type
Observational

Eligibility Criteria

Ages
1.00 Day(s) to 7.00 Day(s) (—)
Sex
All

Inclusion Criteria

  • Neonates with a clinical diagnosis of sepsis, who are blood culture positive or Neonates with clinical diagnosis of sepsis with 2 or more of the following positive lab criteria [TLC<5000/mm3, low absolute neutrophil count, immature to total neutrophil ratio>0.2, CRP-positive].

Exclusion Criteria

  • Neonates with Congenital abnormalities, Those who received blood transfusion or infusion Ringer’s lactate prior to examination, Neonates on 2nd line antibiotics, Asphyxiated neonates.

Outcomes

Primary Outcomes

Mortality

Time Frame: Recruitment | 6 hours | 28 days or earlier

Secondary Outcomes

  • To study complications of neonatal sepsis that might develop in infants with lactate clearance 10% and Modified Sepsis Neonatal Score≤10 who survive till 28days or earlier.(Recruitment, 6hours, 28days or earlier)

Investigators

Sponsor
SHUBHIKA GARG
Sponsor Class
Private medical college

Study Sites (1)

Loading locations...

Similar Trials

Lactate Clearance And Neonatal Sepsis Score | Clinical Trial